Ning Wang

Kuo Yang, Zecong Yu, Xin Su et al. · tsinghua

Treatment planning for chronic diseases is a critical task in medical artificial intelligence, particularly in traditional Chinese medicine (TCM). However, generating optimized sequential treatment strategies for patients with chronic diseases in different clinical encounters remains a challenging issue that requires further exploration. In this study, we proposed a TCM herbal prescription planning framework based on deep reinforcement learning for chronic disease treatment (PrescDRL). PrescDRL is a sequential herbal prescription optimization model that focuses on long-term effectiveness rather than achieving maximum reward at every step, thereby ensuring better patient outcomes. We constructed a high-quality benchmark dataset for sequential diagnosis and treatment of diabetes and evaluated PrescDRL against this benchmark. Our results showed that PrescDRL achieved a higher curative effect, with the single-step reward improving by 117% and 153% compared to doctors. Furthermore, PrescDRL outperformed the benchmark in prescription prediction, with precision improving by 40.5% and recall improving by 63%. Overall, our study demonstrates the potential of using artificial intelligence to improve clinical intelligent diagnosis and treatment in TCM.

Ning Wang

This paper deals with the utterance-level modalities missing problem with uncertain patterns on emotion recognition in conversation (ERC) task. Present models generally predict the speaker's emotions by its current utterance and context, which is degraded by modality missing considerably. Our work proposes a framework Missing-Modality Robust emotion Recognition (M2R2), which trains emotion recognition model with iterative data augmentation by learned common representation. Firstly, a network called Party Attentive Network (PANet) is designed to classify emotions, which tracks all the speakers' states and context. Attention mechanism between speaker with other participants and dialogue topic is used to decentralize dependence on multi-time and multi-party utterances instead of the possible incomplete one. Moreover, the Common Representation Learning (CRL) problem is defined for modality-missing problem. Data imputation methods improved by the adversarial strategy are used here to construct extra features to augment data. Extensive experiments and case studies validate the effectiveness of our methods over baselines for modality-missing emotion recognition on two different datasets.

Zhao Su, Rongxun Liu, Keyin Zhou et al.

Objectives: The study aims to investigate the relationship between insomnia and response time. Additionally, it aims to develop a machine learning model to predict the presence of insomnia in participants using response time data. Methods: A mobile application was designed to administer scale tests and collect response time data from 2729 participants. The relationship between symptom severity and response time was explored, and a machine learning model was developed to predict the presence of insomnia. Results: The result revealed a statistically significant difference (p<.001) in the total response time between participants with or without insomnia symptoms. A correlation was observed between the severity of specific insomnia aspects and response times at the individual questions level. The machine learning model demonstrated a high predictive accuracy of 0.743 in predicting insomnia symptoms based on response time data. Conclusions: These findings highlight the potential utility of response time data to evaluate cognitive and psychological measures, demonstrating the effectiveness of using response time as a diagnostic tool in the assessment of insomnia.

Wei Huang, Ning Wang, Panpan Feng et al.

Electrocardiograms (ECG), which record the electrophysiological activity of the heart, have become a crucial tool for diagnosing these diseases. In recent years, the application of deep learning techniques has significantly improved the performance of ECG signal classification. Multi-resolution feature analysis, which captures and processes information at different time scales, can extract subtle changes and overall trends in ECG signals, showing unique advantages. However, common multi-resolution analysis methods based on simple feature addition or concatenation may lead to the neglect of low-resolution features, affecting model performance. To address this issue, this paper proposes the Multi-Resolution Mutual Learning Network (MRM-Net). MRM-Net includes a dual-resolution attention architecture and a feature complementary mechanism. The dual-resolution attention architecture processes high-resolution and low-resolution features in parallel. Through the attention mechanism, the high-resolution and low-resolution branches can focus on subtle waveform changes and overall rhythm patterns, enhancing the ability to capture critical features in ECG signals. Meanwhile, the feature complementary mechanism introduces mutual feature learning after each layer of the feature extractor. This allows features at different resolutions to reinforce each other, thereby reducing information loss and improving model performance and robustness. Experiments on the PTB-XL and CPSC2018 datasets demonstrate that MRM-Net significantly outperforms existing methods in multi-label ECG classification performance. The code for our framework will be publicly available at https://github.com/wxhdf/MRM.

Junwei Su, Cheng Xin, Ao Shang et al.

This paper systematically reviews recent advances in artificial intelligence (AI), with a particular focus on machine learning (ML), across the entire drug discovery pipeline. Due to the inherent complexity, escalating costs, prolonged timelines, and high failure rates of traditional drug discovery methods, there is a critical need to comprehensively understand how AI/ML can be effectively integrated throughout the full process. Currently available literature reviews often narrowly focus on specific phases or methodologies, neglecting the dependence between key stages such as target identification, hit screening, and lead optimization. To bridge this gap, our review provides a detailed and holistic analysis of AI/ML applications across these core phases, highlighting significant methodological advances and their impacts at each stage. We further illustrate the practical impact of these techniques through an in-depth case study focused on hyperuricemia, gout arthritis, and hyperuricemic nephropathy, highlighting real-world successes in molecular target identification and therapeutic candidate discovery. Additionally, we discuss significant challenges facing AI/ML in drug discovery and outline promising future research directions. Ultimately, this review serves as an essential orientation for researchers aiming to leverage AI/ML to overcome existing bottlenecks and accelerate drug discovery.